Small Cell Carcinoma (DBCOND0036950)

Identifiers

Synonyms
Carcinoma, Small Cell / Small cell carcinoma / Small cell carcinoma (disorder) / Small cell neuroendocrine carcinoma (morphologic abnormality) / Oat cell carcinoma (morphologic abnormality) / Oat cell carcinoma / Small cell carcinoma (morphologic abnormality)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05551117
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumorstreatment2active_not_recruiting
NCT01642251
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancertreatment1 / 2completed
NCT00469222
Hypofractionated Radiotherapy for Small Cell Lung CancerNo drug interventionstreatment1completed
NCT03910660
A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.treatment1 / 2active_not_recruiting
NCT04926181
Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancertreatment2active_not_recruiting
NCT02489903
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)treatment2completed
NCT04028479
The Registry of Oncology Outcomes Associated With Testing and TreatmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT05621837
Quantifying Systemic Immunosuppression to Personalize Cancer TherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00466232
Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancertreatment1completed
NCT02721732
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatictreatment2active_not_recruiting
NCT02881125
Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinomatreatment1completed
NCT00469066
Cone Beam CT Scanning in Lung and Bladder Cancer.No drug interventionsNot AvailableNot Availablecompleted
NCT00907569
Hypofractionated Radiotherapy for Limited Stage Small Cell Lung CancerNo drug interventionstreatment2completed
NCT04854590
IMFINZI Study in Patients With Extensive Stage Small Cell Lung CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00294190
Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancertreatment2completed
NCT00284154
Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancertreatment2completed
NCT01900951
Temozolomide as Maintenance Therapy in Small Cell Lung Cancertreatment2unknown_status
NCT01860898
A Phase I Study of iPS Cell Generation From Patients With COPDNo drug interventionsbasic_scienceNot Availablecompleted
NCT02675088
Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung CancerNo drug interventionstreatmentNot Availableunknown_status
NCT00359359
A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancertreatment1 / 2completed
NCT02688036
Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLCNo drug interventionstreatment3unknown_status
NCT00324558
Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)treatment2terminated
NCT05461430
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)No drug interventionsNot AvailableNot Availablerecruiting
NCT01470248
Study of Arsenic Trioxide in Small Cell Lung Cancertreatment2completed
NCT05500391
Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote MonitoringNo drug interventionshealth_services_research2recruiting
NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumorstreatment1active_not_recruiting
NCT00191750
A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returnedtreatment2completed
NCT00447421
A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapytreatment1 / 2terminated
NCT00046787
Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancertreatment2completed
NCT00126828
Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung CancerNo drug interventionstreatment1 / 2completed
NCT00537511
A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposidetreatment1 / 2terminated
NCT02608411
TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)treatment2terminated
NCT00094978
Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinumtreatment1terminated
NCT00100256
Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapytreatment1 / 2recruiting
NCT00305942
Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancertreatment2completed
NCT02366741
Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot StudyNo drug interventionspreventionNot Availableunknown_status
NCT00298896
Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancertreatment2completed
NCT03092739
A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer SpecimensNo drug interventionsNot AvailableNot Availablecompleted
NCT00129974
Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancertreatment2terminated
NCT03554473
M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancerstreatment1 / 2recruiting
NCT00412880
BI 2536 Second Line Monotherapy in SCLCtreatment2completed
NCT00826644
Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patienttreatment3completed
NCT03212404
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancerstreatment1recruiting
NCT02034123
Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinomatreatment1terminated